Diageo halves interim dividend as US weakness hits sales

Diageo reported a 4% decline in net sales to $10.5bn for the six months to end-December, with organic sales down 2.8%; operating profit fell 1.2% to $3.1bn and pre-exceptional EPS dropped 2.5% to $0.953. Free cash flow was $1.5bn and net debt was $21.7bn (roughly flat since June), but the board halved the interim dividend to $0.20 from $0.405 and reset payout policy to 30–50% of earnings (minimum $0.50/year) to create financial flexibility for a strategic reset under new CEO Sir Dave Lewis. Management flagged weaker US and Chinese spirits demand, said excluding Chinese white spirits organic sales would have been ~2% higher, and reiterated FY guidance of organic sales down 2–3%, operating profit flat to up low single digits, and $3bn free cash flow guidance.

Analysis

Market structure: Diageo’s dividend halving and reset to a 30–50% payout crystallises a shift from income to balance-sheet repair and active portfolio change. Winners in the near term are cash-rich competitors and private-label consolidators (potential acquirers of non-core Diageo assets) and buyers of IG credit; losers are yield-seeking equity holders and dividend ETFs that overweight DEO. Expect modest share reallocation within global spirits: premium, on‑trade and travel‑retail brands with resilient margins will gain pricing power while mainstream US spirits volumes remain under pressure.

Risk assessment: Tail risks include a deeper US consumer slump (sales down >5% YoY), a renewed sharp slowdown in China or activist-driven forced M&A that dilutes value; these could push DEO equity down 20–40% in severe scenarios. Immediate risks (days) are volatility and sentiment flows post-announcement; short term (weeks–months) are guidance revisions and Q3 trading statements; long term (quarters–years) hinge on execution of Lewis’s restructuring and whether the $3bn FCF target holds. Hidden dependency: currency translation (USD reporting vs. GBP listing) and distributor inventory destocking can amplify reported organic declines.

Trade implications: Tactical: bias short/hedged on DEO into next 3–6 months while monitoring US CPI and China trade volumes; credit spreads likely widen 25–75bps — bid protection or CDS is attractive if spread > baseline +50bps. Relative longs: reallocate to Pernod (PDRDY) or Brown‑Forman (BF‑B) if they show stronger US pricing or China exposure; implement options hedges (6‑month put spreads) rather than naked shorts to control tail risk.

Contrarian angles: The market may underprice the option value of a refocused Diageo with lower payout and M&A optionality — if management uses freed cash to buy high-margin brands, upside can be 20–40% over 12–24 months. The immediate sell‑off could be overdone if FCF stays ≥$3bn and net debt remains circa $21.7bn; set accumulation triggers (e.g., >20% share decline or confirmed M&A synergy plan) rather than buying on headline noise.

Key Decisions for Investors

• Initiate a 3% short position in DEO equity for a 3–6 month trade, target 10–20% downside; place a stop‑loss at +8% from entry and trim if DEO confirms sustained organic sales < -3% on next trading update.
• Establish a 2% long vs 2% short pair trade: long PDRDY (Pernod Ricard ADR) and short DEO for 6–12 months to capture relative share gain if Diageo execution stalls; rebalance if Pernod reports organic growth > +2% or Diageo posts FCF < $2.5bn.
• Buy a 3–6 month DEO put spread (long 15% OTM put / short 7.5% OTM put) sized to cover downside risk of the short equity position — limited cost, defined risk if volatility spikes.
• Purchase 3–5 year protection on DEO credit (via CDS or bond puts) if 5y CDS or bond OAS widens by >50bps from current levels, target payoff in scenarios where FCF guidance falls below $2.5bn.
• Reduce consumer staples overweight by 1–2% and rotate into premium spirits/brewers with stable US volumes (e.g., BF‑B) over the next 3 months; accumulate DEO only after a >20% share price decline or clear M&A/restructuring milestones are announced.